Genenta Science S.p.A. (GNTA) surged 84.52 percent to $5.96, up $2.73 on Friday, after the immuno-oncology company announced an expanded strategic collaboration with Anemocyte to advance an off-the-shelf lentiviral vector plasmid DNA technology platform.
The stock traded between $5.68 and $10.00 during the session after opening at $9.88, compared with a previous close of $3.23 on the Nasdaq. Trading volume soared to 19.24 million shares, far exceeding the average of 0.01 million.
Over the past 52 weeks, Genenta shares have traded between $2.56 and $10.00.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.